A quantum chemical study: thoughtful exploration for optimal donors in Y-type dual donor-based dye sensitizers.

Phys Chem Chem Phys

Department of Chemistry (CMDD Lab), GITAM School of Science, GITAM (Deemed to be University), Visakhapatnam-530045, AP, India.

Published: October 2023

This research explores the influence of different dual donors on the effectiveness of dye sensitizers. We selected 35 diverse donors to construct Y-type dual donor-based dyes, connecting them with thiophene as the π-spacer and cyanoacrylic acid as the acceptor. Density functional theory calculations indicate that these dual donor-based dyes exhibit superior optoelectronic properties compared to their single donor counterparts. Notably, significant variations in charge distribution among the different dual donors affect their donor capabilities. Our calculations specifically highlight the enhanced thermodynamic parameters, including light harvesting efficiency (LHE), the free energy of dye injection (Δ), and regeneration (Δ), for donor moieties containing nitrogen atoms, such as NS-3 (,-dimethylaniline), NS-5 (diphenylamine), NS-6 (triphenylamine), and NS-8 (4-methoxy--(4-methoxyphenyl)--phenylaniline). These results suggest that nitrogen-containing donor moieties act as promising candidates for donors for efficient dye sensitizers. However, further experimental validation in the near future will be necessary to confirm our findings.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d3cp03899hDOI Listing

Publication Analysis

Top Keywords

dual donor-based
12
dye sensitizers
12
y-type dual
8
dual donors
8
donor-based dyes
8
donor moieties
8
donors
5
dual
5
quantum chemical
4
chemical study
4

Similar Publications

Conn's syndrome, defined as unilateral aldosterone-producing adenoma, accounts for 35-40% of cases of primary hyperaldosteronism. Primary hyperaldosteronism typically occurs in younger patients with poorly controlled arterial hypertension due to extracellular fluid retention, in whom at least a triple combination of antihypertensives, including a diuretic, is needed to maintain normotension. The clinical picture of arterial hypertension may be complemented by symptoms associated with hypokalaemia, such as weakness, fatigue, palpitations, convulsions, polydipsia, or polyuria.

View Article and Find Full Text PDF

This research explores the influence of different dual donors on the effectiveness of dye sensitizers. We selected 35 diverse donors to construct Y-type dual donor-based dyes, connecting them with thiophene as the π-spacer and cyanoacrylic acid as the acceptor. Density functional theory calculations indicate that these dual donor-based dyes exhibit superior optoelectronic properties compared to their single donor counterparts.

View Article and Find Full Text PDF

Critical limb ischemia, the final course of peripheral artery disease, is characterized by an insufficient supply of blood flow and excessive oxidative stress. H S molecular therapy possesses huge potential for accelerating revascularization and scavenging intracellular reactive oxygen species (ROS). Moreover, it is found that BMP6 is the most significantly up-expressed secreted protein-related gene in HUVECs treated with GYY4137, a H S donor, based on the transcriptome analysis.

View Article and Find Full Text PDF

Design, synthesis and anti-ovarian cancer activities of thieno[2,3-d]pyrimidine based chimeric BRD4 inhibitor/nitric oxide-donator.

Eur J Med Chem

January 2023

Department of Dermatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Collaborative Innovation Center of Biotherapy, Chengdu, 610041, China. Electronic address:

Bromodomain protein 4 (BRD4) is an attractive epigenetic target that regulating diverse cellular processes, and the discovery of dual-target inhibitors including BRD4 is an effective approach in cancer treatment to increase potency and reduce drug resistance. Based on the multifunctional drug development strategy, a series of new derivatives of nitrooxy (ONO) or furoxan (1,2,5-oxadiazole 2-oxide) with BRD4 inhibitor capable of inhibiting BRD4 and simultaneously releasing NO were designed and synthesized. When NO concentrations were measured with Griess reagent under physiological conditions, all compounds released NO at micromolar levels, reaching effective antitumor concentrations.

View Article and Find Full Text PDF

N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive HS donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis.

Int J Biol Macromol

June 2022

Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai 264005, PR China; College of Marine Life Science, Ocean University of China, Qingdao 266003, PR China. Electronic address:

Currently, very limited therapeutic approaches are available for the drug treatment of atherosclerosis(AS). HS-donor is becoming a common trend in much life-threatening research. Several studies have documented that HS-lyase is predominantly present in endothelial cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!